Quest Diagnostics Inc Debt Instrument, Fair Value Disclosure
Quest Diagnostics Inc (DGX) had Debt Instrument, Fair Value Disclosure of $5.60 billion as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Notes › Debt
us-gaap:DebtInstrumentFairValue · last filed 2026-07-23
- 2026-06-30: Debt Instrument, Fair Value Disclosure $5.60B.
- 2026-03-31: Debt Instrument, Fair Value Disclosure $5.60B.
- 2025-12-31: Debt Instrument, Fair Value Disclosure $5.70B.
- 2025-09-30: Debt Instrument, Fair Value Disclosure $5.70B.
| Period end | Debt Instrument, Fair Value Disclosure |
|---|---|
| 2026-06-30 | $5.60B 10-Q · filed 2026-07-23 |
| 2026-03-31 | $5.60B 10-Q · filed 2026-04-22 |
| 2025-12-31 | $5.70B 10-Q · filed 2026-07-23 |
| 2025-09-30 | $5.70B 10-Q · filed 2025-10-21 |
| 2025-06-30 | $5.60B 10-Q · filed 2025-07-23 |
| 2025-03-31 | $5.80B 10-Q · filed 2025-04-23 |
| 2024-12-31 | $6.10B 10-K · filed 2026-02-26 |
| 2024-09-30 | $6.30B 10-Q · filed 2024-10-23 |
| 2024-06-30 | $4.30B 10-Q · filed 2024-07-24 |
| 2024-03-31 | $4.60B 10-Q · filed 2024-04-24 |
| 2023-12-31 | $4.60B 10-K · filed 2025-02-20 |
| 2023-09-30 | $3.90B 10-Q · filed 2023-10-25 |
| 2023-06-30 | $4.00B 10-Q · filed 2023-07-27 |
| 2023-03-31 | $3.80B 10-Q · filed 2023-04-28 |
| 2022-12-31 | $3.70B 10-K · filed 2024-02-22 |
| 2022-09-30 | $3.60B 10-Q · filed 2022-10-21 |
| 2022-06-30 | $3.80B 10-Q · filed 2022-07-22 |
| 2022-03-31 | $4.10B 10-Q · filed 2022-04-22 |
| 2021-12-31 | $4.40B 10-K · filed 2023-02-21 |
| 2021-09-30 | $4.50B 10-Q · filed 2021-10-22 |
| 2021-06-30 | $4.50B 10-Q · filed 2021-07-23 |
| 2021-03-31 | $4.40B 10-Q · filed 2021-04-23 |
| 2020-12-31 | $4.60B 10-K · filed 2022-02-28 |
| 2020-09-30 | $5.20B 10-Q · filed 2020-10-23 |
| 2020-06-30 | $5.10B 10-Q · filed 2020-07-24 |
| 2020-03-31 | $4.30B 10-Q · filed 2020-05-04 |
| 2019-12-31 | $5.10B 10-K · filed 2021-02-22 |
| 2019-09-30 | $4.30B 10-Q · filed 2019-10-23 |
| 2019-06-30 | $4.20B 10-Q · filed 2019-07-24 |
| 2019-03-31 | $4.40B 10-Q · filed 2019-04-24 |
| 2018-12-31 | $4.00B 10-K · filed 2020-02-20 |
| 2018-09-30 | $3.80B 10-Q · filed 2018-10-24 |
| 2018-06-30 | $3.90B 10-Q · filed 2018-07-25 |
| 2018-03-31 | $4.10B 10-Q · filed 2018-04-20 |
| 2017-12-31 | $4.00B 10-K · filed 2019-02-21 |
| 2017-09-30 | $4.00B 10-Q · filed 2017-10-19 |
| 2017-06-30 | $4.00B 10-Q · filed 2017-07-25 |
| 2017-03-31 | $3.90B 10-Q · filed 2017-04-21 |
| 2016-12-31 | $3.90B 10-K · filed 2018-02-23 |
| 2016-09-30 | $4.10B 10-Q · filed 2016-10-21 |
| 2016-06-30 | $4.10B 10-Q · filed 2016-07-25 |
| 2016-03-31 | $4.00B 10-Q · filed 2016-04-27 |
| 2015-12-31 | $3.70B 10-K · filed 2017-02-22 |
| 2015-09-30 | $3.80B 10-Q · filed 2015-10-29 |
| 2015-06-30 | $3.80B 10-Q · filed 2015-07-30 |
| 2015-03-31 | $5.10B 10-Q · filed 2015-04-30 |
| 2014-12-31 | $4.20B 10-K · filed 2016-02-26 |
| 2014-09-30 | $4.20B 10-Q · filed 2014-10-30 |
| 2014-06-30 | $4.30B 10-Q · filed 2014-07-31 |
| 2014-03-31 | $4.20B 10-Q · filed 2014-05-01 |
| 2013-12-31 | $3.50B 10-K · filed 2015-02-24 |
| 2013-09-30 | $3.60B 10-Q · filed 2013-10-24 |
| 2013-06-30 | $3.80B 10-Q · filed 2013-07-25 |
| 2013-03-31 | $3.80B 10-Q · filed 2013-04-24 |
| 2012-12-31 | $3.80B 10-K · filed 2014-02-18 |
| 2012-09-30 | $4.10B 10-Q · filed 2012-10-24 |
| 2012-06-30 | $4.30B 10-Q · filed 2012-07-26 |
| 2012-03-31 | $4.30B 10-Q · filed 2012-04-27 |
| 2011-12-31 | $4.40B 10-K · filed 2013-02-27 |
| 2011-09-30 | $4.60B 10-Q · filed 2011-11-03 |
| 2011-06-30 | $4.60B 10-Q · filed 2011-07-27 |
| 2011-03-31 | $4.40B 10-Q · filed 2011-05-10 |
| 2010-12-31 | $3.10B 10-K · filed 2012-02-16 |
| 2010-09-30 | $3.40B 10-Q · filed 2010-10-26 |
| 2010-06-30 | $3.30B 10-Q · filed 2010-07-27 |
| 2009-12-31 | $3.30B 10-K · filed 2011-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |